Welcome to the Media Centre
This section provides details of new items added to the site as well as a full archive of our press releases and statements.
The opening hours for the Press Office are Monday to Friday between 9:00 and 17:00.
The Press Office
151 Buckingham Palace Road
Main telephone: 020 3080 7651
Out of hours: 07770 446 189
For urgent calls outside these press office hours please contact the duty press officer on : 07770 446 189.
We now have a Twitter channel for press releases and news statements, giving you another way to find out the latest news from the MHRA in real time.Follow @MHRApress
Press enquiries should be made through the Press Office.
Latest news and press releases
An advertisement for the post of MHRA chairman appeared in the Sunday Times on 20 July 2014.
24 Jul 2014 | Levonorgestrel and ulipristal remain suitable emergency contraceptives for all women, regardless of bodyweight
The EMA have concluded its review of emergency contraceptives containing levonorgestrel or ulipristal acetate to assess whether the effectiveness of Levonelle (containing levonorgestrel) and ellaOne (containing ulipristal acetate) was reduced with increased body weight.
24 Jul 2014 | Press release: European review concludes positive benefit risk of emergency contraceptives
Emergency contraceptives continue to be suitable for all women who need them, regardless of the woman’s weight said the Medicines and Healthcare products Regulatory Agency (MHRA) today. These medicines may continue to be used to prevent unintended pregnancies and should be taken as soon as possible after unprotected intercourse or contraceptive failure. This follows a European review that concluded that the benefits of emergency contraceptives continue to outweigh the risks in all women.
21 Jul 2014 | MHRA opioids learning module updated
We have updated our popular learning module on opioids. The changes cover recent concerns about transdermal patches. We have also revised one or two of the self-assessment questions.
People using fentanyl skin (‘transdermal’) patches and their carers should check that the patches are stuck on securely and are disposed of safely. This follows reports to the Medicines and Healthcare products Regulatory Agency (MHRA) of these patches accidentally sticking to other people’s skin on contact.
Photo and image library
This section of the site includes press releases and statements issued by the MHRA.